Nanobionic Clothing Seen to Help Clear Body of Free Radicals Associated with MS and Other Diseases
A recent study in the Journal of Medicinal Chemistry and Toxicology reported that the impact of disease-causing free…
Articles by Charles Moore
Potential Remyelination Therapy for MS, NDC-1308, Advancing in Preclinical Studies
As Multiple Sclerosis News Today reported in mid-July, Endece Neural was issued an additional U.S. patent for its…
MS Association of America Offering Free and Newly Updated Resources to Patients
The Multiple Sclerosis Association of America (MSAA), a national nonprofit organization based in Cherry Hill, New Jersey, announced the availability of…
#CMSC16 — Multiple Sclerosis News Today to Provide Extensive On-Site Coverage of Annual Meeting
Multiple Sclerosis News Today will provide extended on-site coverage of the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting June…
UK Clinical Trials Testing Robotic Legs That Might Allow Patients to Walk Hands-Free
The first U.K. clinical trials of robotic legs that might allow people with mobility impairment to move — hands-free —…
European Program Aims to Develop Wearable Devices to Monitor and Treat MS
A major new European research program to develop ways of monitoring three main central nervous system diseases —multiple sclerosis (MS), depressive disorder,…
Australian MS Researcher Devising Ways to Use Smartwatches as Memory Aids
Dr. Hannah Gullo, a University of Queensland (UQ) School of Health and Rehabilitation Sciences researcher, is several steps closer to…
Multiple Sclerosis News Today to Provide On-site Coverage of 10th World Congress on Controversies in Neurology
The 10th World Congress on Controversies in Neurology (CONy) will be held this week — March 17-20 — in…
Risk of Developing MS May Be Reduced by Drinking Lots of Coffee, Study Says
A new research study published online in the Journal of Neurology, Neurosurgery & Psychiatry suggests that drinking…
Science Fiction Becomes Reality for MS Patients in New Robotic Exoskeleton Study
Wearable robotic exoskeletons may soon help people with advanced multiple sclerosis (MS) walk more efficiently and confidently again. Exoskeleton technology…
MS Treatment and Research Forum, ACTRIMS, Kicks Off Thursday in New Orleans
The first standalone forum held by the Madison, Wisconsin-based Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) gets…
Assess MS: a New Therapy Assessment Tool Developed by Microsoft – Novartis Collaboration
When Microsoft rolled out its original Kinect system for playing Xbox video games in November 2010, the technology caught the…
Multiple Sclerosis Patient and ‘Sopranos’ Actress Takes MS Struggle Public
Millions of television viewers who watched the popular HBO mob drama series “The Sopranos” saw actress Jamie Lynn Sigler grow from a…
FDA Invites Comment on Pending Stem Cell Therapy Regulations
The U.S. Food and Drug Administration (FDA) will hold a one-day public hearing on four recent draft guidelines regarding the regulation of…
Can Cannabinoid Chewing Gum Treat Multiple Sclerosis Pain and Spasticity?
MedChew Rx, by AXIM Biotechnology, the world’s first patented cannabinoid release chewing gum for pain and spasticity in multiple sclerosis (MS),…
Vitally Important UK MS Services Face Critical Challenges According to Study
A major new report published by the U.K. MS Trust has determined that the country’s National Health Services (NHS) programs…
Free MS Exchange Interactive Events Coming to San Antonio and Coral Gables (Miami)
Two upcoming, free events for members of the multiple sclerosis community are to be held during the next few weeks…
Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the 31st Congress of the European Committee for…
Multiple Sclerosis News Today To Provide Live, On-Site Coverage Of 31st Annual #ECTRIMS2015 Congress
The 31st meeting of the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (#ECTRIMS2015)…
New MS Drug To Be Distributed By Global Supply Chain Distributor Durbin
Medical Need Europe, a privately held pharmaceutical company headquartered in Sweden and focused on registration, distribution, marketing and sale…
Clinical Trials Study Cannabis Chewing Gum for MS-Associated Pain and Spasticity
AXIM Biotechnologies, Inc. (AXIM)’s clinical trials testing a new pharmaceutical-grade cannabis chewing gum treatment option for Multiple Sclerosis (MS) pain and…
Could Multiple Sclerosis Sufferers Benefit From Cannabis Chewing Gum?
AXIM Biotechnologies, Inc., a biotechnology company focused on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic…
Canadian Pediatric Demyelinating Disease Network Funding To Help Expand Multiple Sclerosis Research
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation (MSSRF) have announced the awarding of…
Genetics’ Contribution To Multiple Sclerosis Risk Among Ashkenazi Jews Investigated
An Open Access research article published in the journal BMC Medical Genetics notes that multiple sclerosis…
Biogen’s Tecfidera Now The Most Prescribed Oral MS Therapy Globally
Cambridge, Massachusetts based Biogen Inc. has reported its second quarter 2015 results, posting a year-over-year seven percent revenue increase to…
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases Such As MS and IBD
Summit, New Jersey based Celgene Corporation and Receptos, Inc. of San Diego, California, a biopharmaceutical company developing therapeutic…
UK Government’s Progress On Improving Neurology Services For MS, Other Diseases Criticized
The Multiple Sclerosis Trust — a UK charity dedicated to providing information for anyone affected by multiple sclerosis, education…
Kiwi And Aussie Crew Members Join Oceans of Hope Circumnavigation Voyage For MS Ability Awareness
New Zealanders Neil Barnett and Russell Watts, who are both living with Multiple Sclerosis, will join the crew sailing the…
Health Canada Non-Insured Health Benefits Program Approves AUBAGIO for Relapsing Remitting Multiple Sclerosis
Genzyme Canada has announced that Health Canada has approved its 14 mg dose of AUBAGIO as an expedited exception benefit…
Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use
With 26 states plus the District of Columbia now allowing medical marijuana use, according to a recent North American Research…